Benjamin L. Palleiko, CHIEF EXECUTIVE OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 8,932 shares at $14.48 ($129K) on 2025-11-18, disclosed to the SEC on 2025-11-19.
Seasonal sale ($129k) by CHIEF EXECUTIVE OFFICER — this insider has traded KALV in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.48 | 4,466 | $65K | 50.0% |
| 2 | $14.48 | 4,466 | $65K | 50.0% |
| Total | $14.48 avg | 8,932 | $129K | 100% |
| Filing → |
| KALV | SELL | 2026-05-13 | $89K | — | Filing → |
| KALV | SELL | 2026-04-20 | $193K | — | Filing → |
| KALV | SELL | 2026-03-10 | $108K | — | Filing → |